Below please find several of the scientific publications and presentations developed by members of the Dicerna clinical development team.
The findings published below play an integral role in the creation, development and optimization of our GalXC™ RNAi technology platform. Dicerna’s scientists are working to discover and develop next-generation therapies that aim to restore health by silencing the genes that cause or contribute to disease.